{"entity":{"type":"insider","cik":"0001731509","url":"/insider/0001731509","json_url":"/insider/0001731509.json","name":"SB INVESTMENT ADVISERS (UK) LTD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":177,"n_filings":88,"first":"2019-03-14","last":"2026-01-20","span_basis":"filed_date"},"name_variants":[{"name":"SB INVESTMENT ADVISERS (UK) LTD","source":"filing","n_filings":88,"first_seen":"2019-03-14","last_seen":"2026-01-20"}],"transactions":[{"id":5871341,"accession":"0001493152-26-002946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-002946","line_url":"/filing/0001493152-26-002946#line-1","is_derivative":false,"issuer_cik":"0001731509","issuer_name":"Energy Vault Holdings, Inc.","issuer_ticker":"NRGV","issuer_name_source":null,"issuer_url":"/issuer/0001731509","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M2) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000000.0,"shares_display":"3,000,000","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":16950000.0,"total_display":"16,950,000.00","total_whole":"16,950,000","shares_owned_after":15535631.0,"shares_owned_after_display":"15,535,631","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":4815468,"accession":"0001493152-25-025970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-025970","line_url":"/filing/0001493152-25-025970#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.; SVF Endurance (Cayman) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191854.0,"shares_display":"191,854","price_per_share":5.9826,"price_display":"5.98","price_state":"stated","total_value":1147785.7404,"total_display":"1,147,785.74","total_whole":"1,147,786","shares_owned_after":13728924.0,"shares_owned_after_display":"13,728,924","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4783222,"accession":"0001493152-25-025571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-025571","line_url":"/filing/0001493152-25-025571#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61493.0,"shares_display":"61,493","price_per_share":6.44,"price_display":"6.44","price_state":"stated","total_value":396014.92,"total_display":"396,014.92","total_whole":"396,015","shares_owned_after":13920778.0,"shares_owned_after_display":"13,920,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-01","scope":"insider"},{"id":4783219,"accession":"0001493152-25-025571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-025571","line_url":"/filing/0001493152-25-025571#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127938.0,"shares_display":"127,938","price_per_share":6.391,"price_display":"6.39","price_state":"stated","total_value":817651.758,"total_display":"817,651.76","total_whole":"817,652","shares_owned_after":13982271.0,"shares_owned_after_display":"13,982,271","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":4513955,"accession":"0001493152-25-025161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-025161","line_url":"/filing/0001493152-25-025161#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.; SVF Endurance (Cayman) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235971.0,"shares_display":"235,971","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":1505494.98,"total_display":"1,505,494.98","total_whole":"1,505,495","shares_owned_after":14110209.0,"shares_owned_after_display":"14,110,209","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4513952,"accession":"0001493152-25-025161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-025161","line_url":"/filing/0001493152-25-025161#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.; SVF Endurance (Cayman) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":227803.0,"shares_display":"227,803","price_per_share":6.1491,"price_display":"6.15","price_state":"stated","total_value":1400783.4273,"total_display":"1,400,783.43","total_whole":"1,400,783","shares_owned_after":14346180.0,"shares_owned_after_display":"14,346,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4257288,"accession":"0001493152-25-020240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-020240","line_url":"/filing/0001493152-25-020240#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":6.49,"price_display":"6.49","price_state":"stated","total_value":649.0,"total_display":"649.00","total_whole":"649","shares_owned_after":14573983.0,"shares_owned_after_display":"14,573,983","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-29","filed_date":"2025-10-30","scope":"insider"},{"id":4257282,"accession":"0001493152-25-020240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-020240","line_url":"/filing/0001493152-25-020240#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24453.0,"shares_display":"24,453","price_per_share":6.5025,"price_display":"6.50","price_state":"stated","total_value":159005.6325,"total_display":"159,005.63","total_whole":"159,006","shares_owned_after":14574083.0,"shares_owned_after_display":"14,574,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":4257277,"accession":"0001493152-25-019892","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-019892","line_url":"/filing/0001493152-25-019892#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66403.0,"shares_display":"66,403","price_per_share":6.0477,"price_display":"6.05","price_state":"stated","total_value":401585.4231,"total_display":"401,585.42","total_whole":"401,585","shares_owned_after":14598536.0,"shares_owned_after_display":"14,598,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-28","scope":"insider"},{"id":4257270,"accession":"0001493152-25-019892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-019892","line_url":"/filing/0001493152-25-019892#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46696.0,"shares_display":"46,696","price_per_share":5.9595,"price_display":"5.96","price_state":"stated","total_value":278284.812,"total_display":"278,284.81","total_whole":"278,285","shares_owned_after":14664939.0,"shares_owned_after_display":"14,664,939","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-24","filed_date":"2025-10-28","scope":"insider"},{"id":4925940,"accession":"0001493152-25-019309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-019309","line_url":"/filing/0001493152-25-019309#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154383.0,"shares_display":"154,383","price_per_share":5.9898,"price_display":"5.99","price_state":"stated","total_value":924723.2934,"total_display":"924,723.29","total_whole":"924,723","shares_owned_after":14711635.0,"shares_owned_after_display":"14,711,635","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-23","filed_date":"2025-10-24","scope":"insider"},{"id":4925937,"accession":"0001493152-25-019309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-019309","line_url":"/filing/0001493152-25-019309#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144266.0,"shares_display":"144,266","price_per_share":6.1529,"price_display":"6.15","price_state":"stated","total_value":887654.2714,"total_display":"887,654.27","total_whole":"887,654","shares_owned_after":14866018.0,"shares_owned_after_display":"14,866,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-22","filed_date":"2025-10-24","scope":"insider"},{"id":4178723,"accession":"0001493152-25-018917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-018917","line_url":"/filing/0001493152-25-018917#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109675.0,"shares_display":"109,675","price_per_share":6.3002,"price_display":"6.30","price_state":"stated","total_value":690974.435,"total_display":"690,974.44","total_whole":"690,974","shares_owned_after":15010284.0,"shares_owned_after_display":"15,010,284","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-22","scope":"insider"},{"id":4178719,"accession":"0001493152-25-018917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-018917","line_url":"/filing/0001493152-25-018917#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220535.0,"shares_display":"220,535","price_per_share":6.1998,"price_display":"6.20","price_state":"stated","total_value":1367272.893,"total_display":"1,367,272.89","total_whole":"1,367,273","shares_owned_after":15119959.0,"shares_owned_after_display":"15,119,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-20","filed_date":"2025-10-22","scope":"insider"},{"id":4217972,"accession":"0001493152-25-018462","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-018462","line_url":"/filing/0001493152-25-018462#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12844.0,"shares_display":"12,844","price_per_share":6.1014,"price_display":"6.10","price_state":"stated","total_value":78366.3816,"total_display":"78,366.38","total_whole":"78,366","shares_owned_after":15340494.0,"shares_owned_after_display":"15,340,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-17","scope":"insider"},{"id":4217968,"accession":"0001493152-25-018462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-018462","line_url":"/filing/0001493152-25-018462#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16671.0,"shares_display":"16,671","price_per_share":6.0702,"price_display":"6.07","price_state":"stated","total_value":101196.3042,"total_display":"101,196.30","total_whole":"101,196","shares_owned_after":15353338.0,"shares_owned_after_display":"15,353,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-17","scope":"insider"},{"id":5012779,"accession":"0001493152-25-018021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-018021","line_url":"/filing/0001493152-25-018021#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":6.0752,"price_display":"6.08","price_state":"stated","total_value":13972.96,"total_display":"13,972.96","total_whole":"13,973","shares_owned_after":15370009.0,"shares_owned_after_display":"15,370,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-10","filed_date":"2025-10-14","scope":"insider"},{"id":5012773,"accession":"0001493152-25-018021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-018021","line_url":"/filing/0001493152-25-018021#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249060.0,"shares_display":"249,060","price_per_share":6.1428,"price_display":"6.14","price_state":"stated","total_value":1529925.768,"total_display":"1,529,925.77","total_whole":"1,529,926","shares_owned_after":15372309.0,"shares_owned_after_display":"15,372,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-14","scope":"insider"},{"id":4056339,"accession":"0001493152-25-017612","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-017612","line_url":"/filing/0001493152-25-017612#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":466242.0,"shares_display":"466,242","price_per_share":6.0479,"price_display":"6.05","price_state":"stated","total_value":2819784.9918,"total_display":"2,819,784.99","total_whole":"2,819,785","shares_owned_after":15621369.0,"shares_owned_after_display":"15,621,369","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-09","scope":"insider"},{"id":4056337,"accession":"0001493152-25-017612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-017612","line_url":"/filing/0001493152-25-017612#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72133.0,"shares_display":"72,133","price_per_share":5.6029,"price_display":"5.60","price_state":"stated","total_value":404153.9857,"total_display":"404,153.99","total_whole":"404,154","shares_owned_after":16087611.0,"shares_owned_after_display":"16,087,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-09","scope":"insider"},{"id":4287664,"accession":"0001493152-25-017300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-017300","line_url":"/filing/0001493152-25-017300#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73955.0,"shares_display":"73,955","price_per_share":5.6878,"price_display":"5.69","price_state":"stated","total_value":420641.249,"total_display":"420,641.25","total_whole":"420,641","shares_owned_after":16159744.0,"shares_owned_after_display":"16,159,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-07","scope":"insider"},{"id":4287662,"accession":"0001493152-25-017300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-017300","line_url":"/filing/0001493152-25-017300#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450342.0,"shares_display":"450,342","price_per_share":5.5553,"price_display":"5.56","price_state":"stated","total_value":2501784.9126,"total_display":"2,501,784.91","total_whole":"2,501,785","shares_owned_after":16233699.0,"shares_owned_after_display":"16,233,699","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4635777,"accession":"0001641172-25-025311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-025311","line_url":"/filing/0001641172-25-025311#line-1","is_derivative":false,"issuer_cik":"0001716729","issuer_name":"Coupang, Inc.","issuer_ticker":"CPNG","issuer_name_source":null,"issuer_url":"/issuer/0001716729","owner_cik":null,"owner_name":"SVF Investments (UK) Ltd; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Investments (UK) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000000.0,"shares_display":"20,000,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":560000000.0,"total_display":"560,000,000.00","total_whole":"560,000,000","shares_owned_after":289542259.0,"shares_owned_after_display":"289,542,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-22","scope":"insider"},{"id":4996541,"accession":"0001641172-25-015491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-015491","line_url":"/filing/0001641172-25-015491#line-1","is_derivative":false,"issuer_cik":"0001716729","issuer_name":"Coupang, Inc.","issuer_ticker":"CPNG","issuer_name_source":null,"issuer_url":"/issuer/0001716729","owner_cik":null,"owner_name":"SVF Investments (UK) Ltd; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Investments (UK) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000000.0,"shares_display":"10,000,000","price_per_share":28.25,"price_display":"28.25","price_state":"stated","total_value":282500000.0,"total_display":"282,500,000.00","total_whole":"282,500,000","shares_owned_after":309542259.0,"shares_owned_after_display":"309,542,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-17","scope":"insider"},{"id":4033583,"accession":"0001641172-25-009791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-009791","line_url":"/filing/0001641172-25-009791#line-1","is_derivative":false,"issuer_cik":"0001716729","issuer_name":"Coupang, Inc.","issuer_ticker":"CPNG","issuer_name_source":null,"issuer_url":"/issuer/0001716729","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Investments (UK) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000000.0,"shares_display":"30,000,000","price_per_share":25.75,"price_display":"25.75","price_state":"stated","total_value":772500000.0,"total_display":"772,500,000.00","total_whole":"772,500,000","shares_owned_after":319542259.0,"shares_owned_after_display":"319,542,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-08","filed_date":"2025-05-12","scope":"insider"},{"id":4811290,"accession":"0001641172-25-000811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-000811","line_url":"/filing/0001641172-25-000811#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Excalibur (Cayman) Ltd; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000000.0,"shares_display":"10,000,000","price_per_share":9.15,"price_display":"9.15","price_state":"stated","total_value":91500000.0,"total_display":"91,500,000.00","total_whole":"91,500,000","shares_owned_after":48070273.0,"shares_owned_after_display":"48,070,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":3256694,"accession":"0001493152-24-050856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-050856","line_url":"/filing/0001493152-24-050856#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Excalibur (Cayman) Ltd; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000000.0,"shares_display":"10,000,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":63300000.0,"total_display":"63,300,000.00","total_whole":"63,300,000","shares_owned_after":58070273.0,"shares_owned_after_display":"58,070,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-19","scope":"insider"},{"id":2727201,"accession":"0001493152-24-036915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-036915","line_url":"/filing/0001493152-24-036915#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SVF Excalibur (Cayman) Ltd; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Excalibur (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500000.0,"shares_display":"7,500,000","price_per_share":6.24,"price_display":"6.24","price_state":"stated","total_value":46800000.0,"total_display":"46,800,000.00","total_whole":"46,800,000","shares_owned_after":68070273.0,"shares_owned_after_display":"68,070,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-17","scope":"insider"},{"id":3081419,"accession":"0001493152-24-020806","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-020806","line_url":"/filing/0001493152-24-020806#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SVF Excalibur (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16900000.0,"shares_display":"16,900,000","price_per_share":4.3,"price_display":"4.30","price_state":"stated","total_value":72670000.0,"total_display":"72,670,000.00","total_whole":"72,670,000","shares_owned_after":75570273.0,"shares_owned_after_display":"75,570,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":3127474,"accession":"0001493152-24-009998","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-24-009998","line_url":"/filing/0001493152-24-009998#line-3","is_derivative":false,"issuer_cik":"0001716729","issuer_name":"Coupang, Inc.","issuer_ticker":"CPNG","issuer_name_source":null,"issuer_url":"/issuer/0001716729","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Investments (UK) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000000.0,"shares_display":"15,000,000","price_per_share":19.6,"price_display":"19.60","price_state":"stated","total_value":294000000.0,"total_display":"294,000,000.00","total_whole":"294,000,000","shares_owned_after":349542259.0,"shares_owned_after_display":"349,542,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-14","scope":"insider"},{"id":3127470,"accession":"0001493152-24-009998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-009998","line_url":"/filing/0001493152-24-009998","is_derivative":false,"issuer_cik":"0001716729","issuer_name":"Coupang, Inc.","issuer_ticker":"CPNG","issuer_name_source":null,"issuer_url":"/issuer/0001716729","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Investments (UK) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31614154.0,"shares_display":"31,614,154","price_per_share":19.008169166177908,"price_display":"19.01","price_state":"stated","total_value":600927187.2776,"total_display":"600,927,187.28","total_whole":"600,927,187","shares_owned_after":365066967.0,"shares_owned_after_display":"365,066,967","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-14","scope":"insider","n_lines":2},{"id":2046052,"accession":"0001493152-24-002111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-002111","line_url":"/filing/0001493152-24-002111#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SVF Excalibur (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000000.0,"shares_display":"10,000,000","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":36600000.0,"total_display":"36,600,000.00","total_whole":"36,600,000","shares_owned_after":92470273.0,"shares_owned_after_display":"92,470,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider"},{"id":8368056,"accession":"0001493152-23-045325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-045325","line_url":"/filing/0001493152-23-045325#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.; SVF Endurance (Cayman) Ltd; SVF Excalibur (Cayman) Ltd","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14895000.0,"shares_display":"14,895,000","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":39620700.0,"total_display":"39,620,700.00","total_whole":"39,620,700","shares_owned_after":102470273.0,"shares_owned_after_display":"102,470,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":8746825,"accession":"0001493152-23-043471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-043471","line_url":"/filing/0001493152-23-043471#line-1","is_derivative":false,"issuer_cik":"0001716729","issuer_name":"Coupang, Inc.","issuer_ticker":"CPNG","issuer_name_source":null,"issuer_url":"/issuer/0001716729","owner_cik":null,"owner_name":"SVF Investments (UK) Ltd; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Investments (UK) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000000.0,"shares_display":"30,000,000","price_per_share":15.39,"price_display":"15.39","price_state":"stated","total_value":461700000.0,"total_display":"461,700,000.00","total_whole":"461,700,000","shares_owned_after":396156413.0,"shares_owned_after_display":"396,156,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider"},{"id":8353525,"accession":"0000950170-23-051247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-051247","line_url":"/filing/0000950170-23-051247#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Holdings (UK) LLP; SVF Investments (UK) Ltd; SoftBank Vision Fund L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000000.0,"shares_display":"10,000,000","price_per_share":12.6,"price_display":"12.60","price_state":"stated","total_value":126000000.0,"total_display":"126,000,000.00","total_whole":"126,000,000","shares_owned_after":73031667.0,"shares_owned_after_display":"73,031,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":8620281,"accession":"0000899243-23-017010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-017010","line_url":"/filing/0000899243-23-017010#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":25.11,"price_display":"25.11","price_state":"stated","total_value":17577.0,"total_display":"17,577.00","total_whole":"17,577","shares_owned_after":16684041.0,"shares_owned_after_display":"16,684,041","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-07-05","scope":"insider"},{"id":8388692,"accession":"0000899243-23-016775","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-016775","line_url":"/filing/0000899243-23-016775#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89942.0,"shares_display":"89,942","price_per_share":25.1799,"price_display":"25.18","price_state":"stated","total_value":2264730.5658,"total_display":"2,264,730.57","total_whole":"2,264,731","shares_owned_after":16684741.0,"shares_owned_after_display":"16,684,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-06-30","scope":"insider"},{"id":8388687,"accession":"0000899243-23-016775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-016775","line_url":"/filing/0000899243-23-016775#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7010.0,"shares_display":"7,010","price_per_share":25.0958,"price_display":"25.10","price_state":"stated","total_value":175921.558,"total_display":"175,921.56","total_whole":"175,922","shares_owned_after":16774683.0,"shares_owned_after_display":"16,774,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-30","scope":"insider"},{"id":8244722,"accession":"0000899243-23-016308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-016308","line_url":"/filing/0000899243-23-016308#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9902.0,"shares_display":"9,902","price_per_share":25.1769,"price_display":"25.18","price_state":"stated","total_value":249301.6638,"total_display":"249,301.66","total_whole":"249,302","shares_owned_after":16781693.0,"shares_owned_after_display":"16,781,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":7834491,"accession":"0000899243-23-016075","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-016075","line_url":"/filing/0000899243-23-016075","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128144.0,"shares_display":"128,144","price_per_share":25.43216623876264,"price_display":"25.43","price_state":"stated","total_value":3258979.5105,"total_display":"3,258,979.51","total_whole":"3,258,980","shares_owned_after":16808632.0,"shares_owned_after_display":"16,808,632","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider","n_lines":2},{"id":7834485,"accession":"0000899243-23-016075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-016075","line_url":"/filing/0000899243-23-016075","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55182.0,"shares_display":"55,182","price_per_share":25.85407748903628,"price_display":"25.85","price_state":"stated","total_value":1426679.704,"total_display":"1,426,679.70","total_whole":"1,426,680","shares_owned_after":16922156.0,"shares_owned_after_display":"16,922,156","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider","n_lines":2},{"id":7993500,"accession":"0000899243-23-015663","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-015663","line_url":"/filing/0000899243-23-015663","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57248.0,"shares_display":"57,248","price_per_share":26.125241199692567,"price_display":"26.13","price_state":"stated","total_value":1495617.8082,"total_display":"1,495,617.81","total_whole":"1,495,618","shares_owned_after":16974921.0,"shares_owned_after_display":"16,974,921","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider","n_lines":2},{"id":7993498,"accession":"0000899243-23-015663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-015663","line_url":"/filing/0000899243-23-015663","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SB INVESTMENT ADVISERS (UK) LTD; SVF Endurance (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.","owner_display_name":"SB INVESTMENT ADVISERS (UK) LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106854.0,"shares_display":"106,854","price_per_share":27.0853725410373,"price_display":"27.09","price_state":"stated","total_value":2894180.3975,"total_display":"2,894,180.40","total_whole":"2,894,180","shares_owned_after":17032169.0,"shares_owned_after_display":"17,032,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider","n_lines":2},{"id":8388622,"accession":"0000899243-23-015323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-015323","line_url":"/filing/0000899243-23-015323#line-1","is_derivative":false,"issuer_cik":"0001563190","issuer_name":"Compass, Inc.","issuer_ticker":"COMP","issuer_name_source":null,"issuer_url":"/issuer/0001563190","owner_cik":null,"owner_name":"SVF Endurance (Cayman) Ltd; SVF Excalibur (Cayman) Ltd; SOFTBANK VISION FUND (AIV M1) L.P.; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SVF Endurance (Cayman) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000000.0,"shares_display":"15,000,000","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":55350000.0,"total_display":"55,350,000.00","total_whole":"55,350,000","shares_owned_after":117365273.0,"shares_owned_after_display":"117,365,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-09","scope":"insider"},{"id":7939302,"accession":"0000899243-23-014628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-014628","line_url":"/filing/0000899243-23-014628#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":null,"owner_name":"SOFTBANK VISION FUND (AIV M1) L.P.; SVF Endurance (Cayman) Ltd; SB INVESTMENT ADVISERS (UK) LTD","owner_display_name":"SOFTBANK VISION FUND (AIV M1) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5197.0,"shares_display":"5,197","price_per_share":27.3231,"price_display":"27.32","price_state":"stated","total_value":141998.1507,"total_display":"141,998.15","total_whole":"141,998","shares_owned_after":17139023.0,"shares_owned_after_display":"17,139,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-06","scope":"insider"}],"collapsed":true,"next_cursor":"2023-06-05|7939302","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828536","name":"Energy Vault Holdings, Inc.","url":"/issuer/0001828536","role":"Ten percent owner","n_filings":1,"first_seen":"2026-01-20","last_seen":"2026-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Ten percent owner","n_filings":58,"first_seen":"2019-10-17","last_seen":"2025-12-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001834584","name":"Coupang, Inc.","url":"/issuer/0001834584","role":"Ten percent owner","n_filings":8,"first_seen":"2021-09-16","last_seen":"2025-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001563190","name":"Compass, Inc.","url":"/issuer/0001563190","role":"Ten percent owner","n_filings":8,"first_seen":"2021-04-08","last_seen":"2025-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001635088","name":"Roivant Sciences Ltd.","url":"/issuer/0001635088","role":"Ten percent owner","n_filings":3,"first_seen":"2022-11-15","last_seen":"2023-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001792789","name":"DoorDash, Inc.","url":"/issuer/0001792789","role":"Ten percent owner","n_filings":3,"first_seen":"2021-05-21","last_seen":"2021-10-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001801169","name":"Opendoor Technologies Inc.","url":"/issuer/0001801169","role":"Ten percent owner","n_filings":1,"first_seen":"2021-09-20","last_seen":"2021-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001543151","name":"Uber Technologies, Inc","url":"/issuer/0001543151","role":"Ten percent owner","n_filings":1,"first_seen":"2021-01-11","last_seen":"2021-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001576280","name":"Guardant Health, Inc.","url":"/issuer/0001576280","role":"Ten percent owner","n_filings":5,"first_seen":"2019-03-14","last_seen":"2020-10-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001731509","retrieved_at":"2026-08-24T18:11:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}